Cedar Ridge, CA, United States

California Western School of Law

Cedar Ridge, CA, United States

California Western School of Law, founded in 1924, is a private, non-profit law school located in San Diego, California. It is popularly known as California Western or Cal Western and formerly California Western University. The school was approved by the American Bar Association in 1962 and became a member of the Association of American Law Schools in 1967. It is the oldest law school in San Diego. Wikipedia.

Time filter
Source Type

News Article | November 9, 2016
Site: www.prweb.com

Joshua W. Glotzer, APC, a Los Angeles, CA personal injury law firm, has named Brittany Smith as the recipient of its Annual Scholarship for 2016. Ms. Smith is a first-year law student at Boston College of Law. She is originally from Detroit, Michigan, and earned her B.A. at the University of Michigan in Ann Arbor. Ms. Smith’s impressive resume includes an internship at the Whitehouse Office of Communications & Research from May – August of 2013. Attorney Joshua Glotzer launched this scholarship to reward individuals interested in pursuing a legal career. He believes that Ms. Smith perfectly embodies the traits that an aspiring attorney should have: intelligent, hard working, and passionate about her community. About Joshua W. Glotzer, APC and attorney Joshua Glotzer: Personal injury law firm with headquarters in Los Angeles, CA and offices throughout Southern California including Lancaster, Burbank, West Covina, and Anaheim. Mr. Glotzer has over 20 years experience helping accident victims get the compensation they deserve after an accident. He is a graduate of California Western School of Law and has practiced his entire career in Los Angeles, CA. For more information, please visit us online at http://www.socalpersonalinjurylawyer.com.

Mackey T.K.,San Diego State University | Liang B.A.,California Western School of Law
Journal of Public Health Policy | Year: 2012

No formal system exists to review trade restrictions imposed during international public health emergencies rapidly. Failure to put one in place creates disincentives for surveillance and reporting, thereby undermining protection efforts. The 2003 SARS outbreak exposed weaknesses in global governance that caused uncoordinated public health and economic responses. New International Health Regulations (IHR), applied first during the 2009 H1N1 influenza outbreak, demonstrated improvement. Yet they failed to allow for management of public health emergencies in a way that balanced threats to health and those to economies and trade. Establishment of a joint WHO-WTO committee to adjudicate these conflicts might better achieve that balance. © 2012 Macmillan Publishers Ltd.

Liang B.A.,University of San Diego | Liang B.A.,California Western School of Law | Mackey T.K.,California Western School of Law | Mackey T.K.,San Diego State University
Journal of Medical Internet Research | Year: 2011

Background: Direct-to-consumer advertising (DTCA), linked to inappropriate medication use and higher health care expenditures, is the fastest growing form of pharmaceutical marketing. DTCA is legal only in the United States and New Zealand. However, the advent of online interactive social media "Web 2.0" technologies-that is, eDTCA 2.0-may circumvent DTCA legal proscriptions. Objective: The purpose of this study was to assess the prevalence of DTCA of leading pharmaceutical company presence and drug product marketing in online interactive social media technologies (eDTCA 2.0). Methods: We conducted a descriptive study of the prevalence of eDTCA 2.0 marketing in the top 10 global pharmaceutical corporations and 10 highest grossing drugs of 2009.Results: All pharmaceutical companies reviewed (10/10, 100%) have a presence in eDTCA 2.0 on Facebook, Twitter/Friendster, sponsored blogs, and really simple syndication (RSS) feeds. In addition, 80% (8/10) have dedicated YouTube channels, and 80% (8/10) developed health care communication-related mobile applications. For reviewed drugs, 90% (9/10) have dedicated websites, 70% (7/10) have dedicated Facebook pages, 90% (9/10) have health communications-related Twitter and Friendster traffic, and 80% (8/10) have DTCA television advertisements on YouTube. We also found 90% (9/10) of these drugs had a non-corporate eDTCA 2.0 marketing presence by illegal online drug sellers. Conclusion: Pharmaceutical companies use eDTCA 2.0 to market themselves and their top-selling drugs. eDTCA 2.0 is also used by illicit online drug sellers. Regulators worldwide must take into account the current eDTCA 2.0 presence when attempting to reach policy and safety goals.

News Article | February 15, 2017
Site: www.prweb.com

Immigration attorney Tifany Markee is celebrating fifteen years as a legal professional. “More important than the number of years I have practiced is my ability to look back and see my work pay off for individuals, families and companies throughout the world,” said Ms. Markee, a partner at Milner & Markee, LLP. “I know that my dedication and commitment to improving my profession has made a true difference, and for that I am very proud. I look forward to the next fifteen years with equal excitement.” Ms. Markee received her Juris Doctor from California Western School of Law, graduating Magna Cum Laude in May 2001. She is currently an active member of the California State Bar and American Immigration Lawyers Association. She is also a Certified Specialist in U.S. Immigration and Nationality law by the State Bar of California. Furthermore, Ms. Markee, the mother of two internationally adopted children, is one of only a handful of attorneys across the nation with an active practice in the adoption, immigration, and citizenship of foreign-born children. She is an active lecturer and mentor in this field and frequently speaks at law schools and professional organizations, including the American Immigration Lawyers Association and Academy of California Adoption Attorneys. “Tifany has dedicated herself to this demanding field of law, and has successfully presented and assisted with cases before the CIS, Board of Immigration Appeals, the Ninth Circuit Court of Appeals and the United States Federal District Courts,” said Nora Milner, senior partner at Milner & Markee. “The firm is very fortunate to have her unique skills and experience in international adoptions.” About Milner & Markee, LLP Since 1987, Milner & Markee has focused on Immigration and Nationality Law. Milner & Markee maintains two offices, one in San Diego and one in Palm Desert, CA. For more information, please call (858) 451-6269, or visit http://www.milner-markee.com. About the NALA™ The NALA offers small and medium-sized businesses effective ways to reach customers through new media. As a single-agency source, the NALA helps businesses flourish in their local community. The NALA’s mission is to promote a business’ relevant and newsworthy events and achievements, both online and through traditional media. For media inquiries, please call 805.650.6121, ext. 361.

Liang B.A.,California Western School of Law
Journal of medical Internet research | Year: 2012

Unprecedented drug shortages announced by the US Food and Drug Administration (FDA) have severely affected therapeutic access, patient safety, and public health. With continued shortages, patients may seek drugs online. To assess the prevalence of online marketing for current FDA shortage drugs and potential patient safety risks. We performed a descriptive study of the prevalence of online marketing for shortage drugs-that is, offers for sale of each drug, including characteristics of online drug sellers and intermediary sites marketing these drugs. Of the 72 FDA shortage-listed drugs, 68 (94%) were offered for sale online. We found 291 offers for these drugs, the vast majority (n = 207, 71.1%) by online drug sellers selling direct to consumers. Intermediary sites included data aggregators (n = 22, 8%), forum links (n = 23, 8%), and personal page data links (n = 34, 12%), as well as Flickr social media links (n = 5, 2%), all advertising drugs without a prescription. Of the 91 online drug sellers identified, 31 (34%) had more than 1 shortage drug offered for sale, representing most (n = 148, 71%) of all online drug seller sales offers. The majority of these online drug sellers (n = 21, 68%) were on the National Association of Boards of Pharmacy (NABP) Not Recommended Sites list. Finally, for shortage drugs with an online drug seller (n = 58, 85%), 53 (91%) had at least one site on the Not Recommended list and 21 (36%) had only sites on the Not Recommended list. FDA shortage drugs are widely marketed over the Internet. Suspect online drug sellers and intermediaries dominate these sales offers. As a critical risk management issue, patients, providers, and policymakers should be extremely cautious in procuring shortage drugs through Internet sourcing.

Mackey T.K.,California Western School of Law | Mackey T.K.,University of California at San Diego | Liang B.A.,University of California at San Diego
Globalization and Health | Year: 2013

Background: Digital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These cybercriminal actors exploit available eDTCA mediums over the Internet to market their suspect products globally. Despite these risks, a detailed assessment of the public health, patient safety, and cybersecurity threats and governance mechanisms to address them has not been conducted.Discussion: Illicit online pharmacies represent a significant global public health and patient safety risk. Existing governance mechanisms are insufficient and include lack of adequate adoption in national regulation, ineffective voluntary governance mechanisms, and uneven global law enforcement efforts that have allowed proliferation of these cybercriminals on the web. In order to effectively address this multistakeholder threat, inclusive global governance strategies that engage the information technology, law enforcement and public health sectors should be established.Summary: Effective global "eHealth Governance" focused on cybercrime is needed in order to effectively combat illicit online pharmacies. This includes building upon existing Internet governance structures and coordinating partnership between the UN Office of Drugs and Crime that leads the global fight against transnational organized crime and the Internet Governance Forum that is shaping the future of Internet governance. Through a UNODC-IGF governance mechanism, investigation, detection and coordination of activities against illicit online pharmacies and their misuse of eDTCA can commence. © 2013 Mackey and Liang; licensee BioMed Central Ltd.

Lovett K.M.,California Western School of Law | Lovett K.M.,University of California at San Diego | Liang B.A.,University of California at San Diego
Nature Reviews Cancer | Year: 2011

Direct-to-consumer online advertising for thermography as a sole agent with which to diagnose breast cancer is misleading and exploits women who are seeking preventive health care for breast cancer. Regulatory action should be taken against companies who continue to mislead the public to ensure patient safety and evidence-based public health information. © 2011 Macmillan Publishers Limited. All rights reserved.

MacKey T.K.,California Western School of Law | MacKey T.K.,University of California at San Diego | Liang B.A.,California Western School of Law | Liang B.A.,University of California at San Diego
Journal of Medical Internet Research | Year: 2013

Background: Illicit or rogue Internet pharmacies are a recognized global public health threat that have been identified as utilizing various forms of online marketing and promotion, including social media. Objective: To assess the accessibility of creating illicit no prescription direct-to-consumer advertising (DTCA) online pharmacy social media marketing (eDTCA2.0) and evaluate its potential global reach. Methods: We identified the top 4 social media platforms allowing eDTCA2.0. After determining applicable platforms (ie, Facebook, Twitter, Google+, and MySpace), we created a fictitious advertisement advertising no prescription drugs online and posted it to the identified social media platforms. Each advertisement linked to a unique website URL that consisted of a site error page. Employing Web search analytics, we tracked the number of users visiting these sites and their location. We used commercially available Internet tools and services, including website hosting, domain registration, and website analytic services. Results: Illicit online pharmacy social media content for Facebook, Twitter, and MySpace remained accessible despite highly questionable and potentially illegal content. Fictitious advertisements promoting illicit sale of drugs generated aggregate unique user traffic of 2795 visits over a 10-month period. Further, traffic to our websites originated from a number of countries, including high-income and middle-income countries, and emerging markets. Conclusions: Our results indicate there are few barriers to entry for social media-based illicit online drug marketing. Further, illicit eDTCA2.0 has globalized outside US borders to other countries through unregulated Internet marketing.

Mackey T.K.,University of California at San Diego | Mackey T.K.,California Western School of Law | Liang B.A.,University of California at San Diego
BMC Medicine | Year: 2013

Background: Perhaps no greater challenge exists for public health, patient safety, and shared global health security, than fake/falsified/fraudulent, poor quality unregulated drugs, also commonly known as "counterfeit medicines", now endemic in the global drug supply chain. Counterfeit medicines are prevalent everywhere, from traditional healthcare settings to unregulated sectors, including the Internet. These dangerous medicines are expanding in both therapeutic and geographic scope, threatening patient lives, leading to antimicrobial resistance, and profiting criminal actors.Discussion: Despite clear global public health threats, surveillance for counterfeit medicines remains extremely limited, with available data pointing to an increasing global criminal trade that has yet to be addressed appropriately. Efforts by a variety of public and private sector entities, national governments, and international organizations have made inroads in combating this illicit trade, but are stymied by ineffectual governance and divergent interests. Specifically, recent efforts by the World Health Organization, the primary international public health agency, have failed to adequately incorporate the broad array of stakeholders necessary to combat the problem. This has left the task of combating counterfeit medicines to other organizations such as UN Office of Drugs and Crime and Interpol in order to fill this policy gap.Summary: To address the current failure of the international community to mobilize against the worldwide counterfeit medicines threat, we recommend the establishment of an enhanced global health governance trilateral mechanism between WHO, UNODC, and Interpol to leverage the respective strengths and resources of these organizations. This would allow these critical organizations, already engaged in the fight against counterfeit medicines, to focus on and coordinate their respective domains of transnational crime prevention, public health, and law enforcement field operations. Specifically, by forming a global partnership that focuses on combating the transnational criminal and patient safety elements of this pre-eminent global health problem, there can be progress against counterfeit drugs and their purveyors. © 2013 Mackey and Liang; licensee BioMed Central Ltd.

Sax J.K.,California Western School of Law
Annals of health law / Loyola University Chicago, School of Law, Institute for Health Law | Year: 2012

This Article proposes a new direction for addressing financial conflicts of interest, which plague biomedical research and threaten scientific integrity. This Article descriptively states the controversy surrounding financial conflicts of interest by explaining how these conflicts arise and the damage that can be created as a result. By describing the scientific process, the Article explains that changes to the academic environment may allow the public-private interaction to proceed, without creating the problems associated with financial conflicts of interest. Financial conflicts of interest are created when the profit-seeking motive of a private funding source unduly influences an academic scientist's primary responsibilities. The problem with financial conflicts of interest has grown since the passage of the Bayh-Dole Act in 1980. The cornerstone of current policies to address financial conflicts of interest is disclosure, which is inadequate and unsatisfying. The analysis herein changes the trajectory of current approaches in this area by proposing that an analysis of the underlying environment and behavior leading to conflicts of interest must be considered. This Article proposes the use of behavioral economics to craft a policy that effectively addresses conflicts of interest. To this end, this Article applies research from the field of psychology to understand both the environment of academic scientists as well as to begin to understand how academic scientists make decisions. Drawing on psychology literature, this article proposes that academic scientists may experience cognitive dissonance when faced with a situation in which a conflict of interest may arise. This helps to understand why an academic scientist may make a decision that creates a conflict of interest. In addition, this Article utilizes the results of an empirical study conducted by myself and a colleague. In this study, we asked faculty at five medical schools to respond to an anonymous survey containing hypothetical situations in which a conflict may arise. The combination of the psychology literature and our empirical study can provide support to the creation of new policies. Policy proposals include implementation of default rules, education, and changes to academic requirements. Furthermore, this Article considers ways to incentivize medical centers to implement effective policies as well as changes to intellectual property law.

Loading California Western School of Law collaborators
Loading California Western School of Law collaborators